Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
Teva
Colorcon
Boehringer Ingelheim
Queensland Health
Fuji
AstraZeneca
Express Scripts

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021190

« Back to Dashboard

NDA 021190 describes BUSPAR, which is a drug marketed by Bristol Myers Squibb and is included in two NDAs. Additional details are available on the BUSPAR profile page.

The generic ingredient in BUSPAR is buspirone hydrochloride. There are eighteen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.
Summary for 021190
Tradename:BUSPAR
Applicant:Bristol Myers Squibb
Ingredient:buspirone hydrochloride
Patents:0
Therapeutic Class:Anxiolytics
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 021190

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength5MG
Approval Date:Dec 20, 2000TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength7.5MG
Approval Date:Dec 20, 2000TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength10MG
Approval Date:Dec 20, 2000TE:RLD:No

Expired US Patents for NDA 021190

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb BUSPAR buspirone hydrochloride CAPSULE;ORAL 021190-003 Dec 20, 2000 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride CAPSULE;ORAL 021190-004 Dec 20, 2000 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride CAPSULE;ORAL 021190-001 Dec 20, 2000 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride CAPSULE;ORAL 021190-002 Dec 20, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Fish and Richardson
Johnson and Johnson
Dow
Chubb
Julphar
Queensland Health
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.